0001799869-20-000002.txt : 20200203
0001799869-20-000002.hdr.sgml : 20200203
20200203171021
ACCESSION NUMBER: 0001799869-20-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200131
FILED AS OF DATE: 20200203
DATE AS OF CHANGE: 20200203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Strauss David Eric
CENTRAL INDEX KEY: 0001799869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 20569560
MAIL ADDRESS:
STREET 1: 2130 W. HOLCOMBE BLVD., STE. 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_158076780411407.xml
FORM 4
X0306
4
2020-01-31
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001799869
Strauss David Eric
C/O BELLICUM PHARMACEUTICALS, INC.
611 GATEWAY BLVD., SUITE 820
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Director, Corporate Controller
Stock Option (right to buy)
1.22
2020-01-31
4
A
0
156000
0
A
2030-01-30
Common Stock
156000.0
156000
D
25% of the shares subject to the stock option vest and become exercisable on January 31, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
/s/ David E. Strauss
2020-01-31